Uncomplicated UTIs: Antibiotics lasting over 7 days tied to adverse events - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Uncomplicated UTIs: Antibiotics lasting over 7 days tied to adverse events

  • By

  • Olivia Anderson

  • October 21, 2026

  • 3 min

Share

Clinical Scorecard: Uncomplicated UTIs: Courses of at least 8 days associated with higher adverse-event rates

At a Glance

Category

Detail

Condition

Symptomatic uncomplicated urinary tract infections

Key Mechanisms

The study evaluated associations between antibiotic treatment duration and treatment-related adverse-event rates; it did not establish causation.

Target Population

57,448 female patients aged 12 years or older who received an antibiotic prescription within 5 days of diagnosis and had at least 12 months of prior electronic health record activity

Care Setting

U.S. electronic health records from Optum’s de-identified Market Clarity database covering May 2023 through March 2025

Key Highlights

  • The retrospective study compared antibiotic courses lasting at least 8 days with courses lasting 5 to 7 days.

  • Extended treatment was associated with a 20% higher overall rate of treatment-related adverse events (rate ratio, 1.20; 95% CI, 1.09–1.32; P < 0.001).

  • Higher rates were also reported for gastrointestinal, genitourinary, endocrine and hypersensitivity events.

  • Patients receiving extended treatment were older on average and had more coexisting medical conditions.

  • Nitrofurantoin was the most commonly prescribed antibiotic in both groups.

  • Findings were presented at IDWeek 2026.

Guideline-Based Recommendations

The source article reports an observational study and the authors’ stewardship interpretation rather than a clinical guideline.

Diagnosis

  • Eligible patients had symptomatic uncomplicated urinary tract infections and received an antibiotic prescription within 5 days of diagnosis.

  • The source article does not provide detailed diagnostic criteria or testing recommendations.

Management

  • The authors emphasized aligning antibiotic treatment duration with antimicrobial stewardship guidelines.

  • The comparison involved courses lasting at least 8 days versus 5 to 7 days; it did not establish the optimal duration for each antibiotic.

  • Other commonly prescribed agents included beta-lactams, trimethoprim-sulfamethoxazole and fluoroquinolones.

  • The source article does not provide agent-specific treatment recommendations or doses.

Monitoring & Follow-up

  • Treatment duration was categorized during a 7-day period beginning with the first antibiotic prescription.

  • Treatment-related adverse events were assessed for up to 90 days after that period.

  • This was the study’s observation window, not a recommended patient follow-up schedule.

Risks

  • Extended treatment was associated with higher rates of gastrointestinal events (rate ratio, 1.42; 95% CI, 1.24–1.63), genitourinary events (1.52; 95% CI, 1.25–1.84), endocrine events (1.40; 95% CI, 1.02–1.91) and hypersensitivity events (2.38; 95% CI, 1.28–4.40).

  • The retrospective design does not establish that longer treatment caused these events.

  • Absolute adverse-event rates and detailed event definitions were not provided in the source article.

Patient & Prescribing Data

Of 57,448 eligible patients, 17,867 (31.1%) received treatment lasting at least 8 days and 39,581 (68.9%) received treatment lasting 5 to 7 days.

Mean age was 55.1 years in the extended-treatment group versus 52.3 years in the shorter-treatment group. Researchers used propensity score weighting to account for differences in patient characteristics.

Nitrofurantoin accounted for 39% of prescriptions in the extended-treatment group and 46.1% in the 5-to-7-day group.

GSK funded the study. Several authors were GSK employees, some reported stock ownership, and Analysis Group received GSK funding to conduct the study. One co-author also reported research support from Pfizer.

Clinical Best Practices

  • Align antibiotic duration with applicable stewardship guidance, as emphasized by the authors.

  • Distinguish the study’s duration categories from agent-specific prescribing recommendations.

  • Interpret the 20% increase as a relative difference in adverse-event rates, not a 20-percentage-point increase or an absolute event rate.

  • Recognize that propensity score weighting addressed patient-characteristic differences but does not turn the observational findings into proof of causation.

Related Resources & Content

  • Uncomplicated UTIs: Antibiotics lasting over 7 days tied to adverse events — Olivia Anderson — IDSA Reporter — October 21, 2026.

  • IDWeek 2026 — Conference at which the findings were presented, according to the source article.

Original Source(s)

Related Content